The introduction of the the medication vial represents a significant shift in the field to weight management . This innovative drug combines dual mechanisms – stimulation of the GLP-1 target and reduction of the DPP-4 factor – suggesting a unique strategy for addressing obesity . Early research findings suggest substantial results in promoting